Biotech news
Pharma
UK-based law firm Potter Clarkson has expanded its intellectual property practice by hiring Nick McDonald and Richard Roberts as a partners and Oliver Laing as a senior associate. 27 September 2016
Americas
The US Food and Drug Administration has approved a biosimilar application by pharmaceutical company Amgen, the fourth such product to be rubberstamped in the country. 26 September 2016
Africa
Teva and Regeneron Pharmaceuticals have combined to develop and commercialise fasinumab, a novel nerve growth factor (NGF) antibody. 22 September 2016
Americas
Allergan has entered into an agreement to acquire Tobira Therapeutics for up to $1.7 billion. 22 September 2016
Biotech
In a session moderated by Dominic Adair of Bristows, panellists at the 2016 AIPPI World Congress in Milan yesterday discussed biosimilars substitution and interchangeability. 20 September 2016
Pharma
Ahead of the Life Sciences IP Summit 2016 from October 20 to 21 at the Hilton London Paddington Hotel, Sarah Porch of C5 previews the main talking points, including Brexit and the UPC. 16 September 2016
Biotech
Pharmaceutical company AbbVie has had its application to strike out a patent case filed against it by Fujifilm Kyowa Kirin Biologics dismissed. 15 September 2016
Americas
Pharmaceutical company Allergan is set to acquire clinical-stage biotechnology company Vitae Pharmaceuticals for $639 million. 15 September 2016
Americas
Biosimilars company Apobiologix has won a patent infringement litigation against Amgen centring on the drugs Grastofil and Lapelga. 13 September 2016
Asia
Japan’s government officials have warned the UK that the Asian country may reconsider its research and development activities in the UK following Brexit. 8 September 2016